#chmp

Collection of chmp news, found 9 news.

Public should wait for Al Zaytun investigation result: Police

Public should wait for Al Zaytun investigation result: Police

  • 15th July 2023

The National Police urged the people to wait for the result of the investigation regarding alleged blasphemous actions ...

Celltrion announces positive results for its cocktail therapy candidates including neutralisation data against Omicron variant

Celltrion announces positive results for its cocktail therapy candidates including neutralisation data against Omicron variant

  • 3rd January 2022

Celltrion Group announced today results for its cocktail therapy candidates including neutralisation data against the ...

Celltrion’s monoclonal antibody treatment regdanvimab, approved by the European Commission for the treatment of COVID-19

Celltrion’s monoclonal antibody treatment regdanvimab, approved by the European Commission for the treatment of COVID-19

  • 15th November 2021

Celltrion Group announced today that the European Commission (EC) has approved Regkirona (regdanvimab, CT-P59), one of ...

Celltrion receives CHMP positive opinion for regdanvimab (CT-P59) as one of the first monoclonal antibodies recommended as a treatment for COVID-19 by the CHMP

Celltrion receives CHMP positive opinion for regdanvimab (CT-P59) as one of the first monoclonal antibodies recommended as a treatment for COVID-19 by the CHMP

  • 12th November 2021

Celltrion Group announced today that the European Medicine’s Agency’s (EMA) Committee for Medicinal Products for ...

Samsung Bioepis' Flixabi® Infliximab biosimilar recommended for approval in the European Union

Samsung Bioepis' Flixabi® Infliximab biosimilar recommended for approval in the European Union

  • 2nd April 2016

- Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal ...

Samsung Bioepis enters the European biopharmaceutical market with Benepali®, the first fusion protein biosimilar approved by the European Commission

Samsung Bioepis enters the European biopharmaceutical market with Benepali®, the first fusion protein biosimilar approved by the European Commission

  • 18th January 2016

- Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a ...

Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea

Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea

  • 4th December 2015

- Samsung Bioepis Co., Ltd. today announced that Korea’s Ministry of Food and Drug Safety (MFDS) has approved ...

Samsung Bioepis Receives Positive CHMP Opinion for the First Etanercept Biosimilar in the European Union

Samsung Bioepis Receives Positive CHMP Opinion for the First Etanercept Biosimilar in the European Union

  • 20th November 2015

- Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal ...

CAPRELSA(TM) (vandetanib) Receives Positive CHMP Opinion in the European Union

CAPRELSA(TM) (vandetanib) Receives Positive CHMP Opinion in the European Union

  • 20th November 2011

-         AstraZeneca today announced that the Marketing Authorisation Application ...